Standard Chemical & Pharmaceutical Co Ltd Cash Flow Reinvestment Rate
Standard Chemical & Pharmaceutical Co Ltd cash flow reinvestment rate. Standard Chemical & Pharmaceutical Co Ltd (1720) has a Cash Flow Reinvestment Rate of 0.38x as of September 2025, reinvesting NT$193.82 Million (capex NT$78.71 Million plus investments NT$-115.11 Million) from operating cash flow of NT$510.55 Million. Explore 1720 operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Standard Chemical & Pharmaceutical Co Ltd (2002–2024)
Cash flow reinvestment rate of Standard Chemical & Pharmaceutical Co Ltd from 2002 to 2024. Historical reinvestment intensity for Standard Chemical & Pharmaceutical Co Ltd across 23 annual periods. Explore 1720 capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Standard Chemical & Pharmaceutical Co Ltd Cash Flow Reinvestment Rate by Year (2002–2024)
Standard Chemical & Pharmaceutical Co Ltd cash flow reinvestment rate by year from 2002 to 2024. Year-by-year capital reinvestment analysis for Standard Chemical & Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see Standard Chemical & Pharmaceutical Co Lt (1720) cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (TWD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.44x | NT$744.16 Million | NT$1.69 Billion | NT$599.61 Million | ▼ -31.8% |
| 2023 | 0.64x | NT$860.59 Million | NT$1.34 Billion | NT$625.70 Million | ▼ -39.0% |
| 2022 | 1.06x | NT$1.30 Billion | NT$1.23 Billion | NT$1.20 Billion | ▲ +104.3% |
| 2021 | 0.52x | NT$427.38 Million | NT$827.03 Million | NT$217.92 Million | ▼ -28.4% |
| 2020 | 0.72x | NT$665.56 Million | NT$922.58 Million | NT$352.49 Million | ▲ +73.5% |
| 2019 | 0.42x | NT$265.30 Million | NT$637.94 Million | NT$179.11 Million | ▲ +10.6% |
| 2018 | 0.38x | NT$182.32 Million | NT$484.94 Million | NT$169.36 Million | ▼ -31.9% |
| 2017 | 0.55x | NT$391.46 Million | NT$708.74 Million | NT$385.64 Million | ▼ -68.9% |
| 2016 | 1.78x | NT$542.75 Million | NT$305.38 Million | NT$177.92 Million | ▲ +442.0% |
| 2015 | 0.33x | NT$213.43 Million | NT$650.87 Million | NT$178.98 Million | ▼ -33.5% |
| 2014 | 0.49x | NT$287.29 Million | NT$582.30 Million | NT$177.53 Million | ▼ -64.5% |
| 2013 | 1.39x | NT$593.96 Million | NT$427.26 Million | NT$422.73 Million | ▲ +126.6% |
| 2012 | 0.61x | NT$246.76 Million | NT$402.25 Million | NT$246.76 Million | ▼ -16.7% |
| 2011 | 0.74x | NT$298.50 Million | NT$405.49 Million | NT$298.50 Million | ▼ -35.2% |
| 2010 | 1.14x | NT$309.66 Million | NT$272.47 Million | NT$309.66 Million | ▲ +170.8% |
| 2009 | 0.42x | NT$266.14 Million | NT$634.23 Million | NT$266.14 Million | ▲ +56.8% |
| 2008 | 0.27x | NT$192.50 Million | NT$719.17 Million | NT$192.50 Million | ▲ +19.1% |
| 2007 | 0.22x | NT$72.72 Million | NT$323.60 Million | NT$72.72 Million | ▼ -15.1% |
| 2006 | 0.26x | NT$95.01 Million | NT$358.75 Million | NT$95.01 Million | ▲ +93.4% |
| 2005 | 0.14x | NT$50.78 Million | NT$370.77 Million | NT$50.78 Million | ▲ +12.2% |
| 2004 | 0.12x | NT$40.95 Million | NT$335.45 Million | NT$40.95 Million | ▼ -77.8% |
| 2003 | 0.55x | NT$149.81 Million | NT$272.89 Million | NT$149.81 Million | ▼ -57.9% |
| 2002 | 1.30x | NT$192.54 Million | NT$147.75 Million | NT$192.54 Million | — |